U-CHAT: Understanding Communication in Health Care to Achieve Trust

Understanding Communication in Health Care to Achieve Trust: A Prospective Longitudinal Investigation of Communication between Pediatric Oncologists, Children/Adolescents with High-Risk Cancer, and their Families at the Stressful Times of Disease Relapse or Progression

Categories:

Quality of Life

Solid Tumor

Diseases Treated:

Non-therapeutic

Eligibility Overview:

Primary oncologist:

  • Attending physician age 18 years or older who provides medical care to patients in the Solid Tumor Clinic at St. Jude Children’s Research Hospital
  • Primary hematology-oncology fellows age 18 or older (audio-recorded disease reevaluation only)

Parents of children with cancer:

  • Age 18 or older
  • Biological parent, step-parent or primary legal guardian
  • Reads and speaks English

Patients:

  • Primary oncologist is enrolled in the study.
  • 30 years old or younger
  • Diagnosed with one or more of the  following diseases:
    • High-risk neuroblastoma
    • Any sarcoma
    • Any carcinoma
    • Desmoplastic small round cell tumor
    • Incompletely resected or metastatic retinoblastoma, Wilms tumor or melanoma
    • Disease has relapsed, progressed or not responded to therapy
  1. Brief Summary

    Communication between pediatric oncologists and parents of children with cancer is integral to the provision of optimal care, particularly during the difficult times of disease relapse or progression. However, little is known about the verbal and nonverbal strategies that pediatric oncologists use or the effectiveness of different communication styles in sharing prognostic information.

    This study will use audio recording technology to analyze conversations between pediatric oncologists and parents at high-stress points of disease relapse or progression. Researchers hope to use the data to develop better ways of communicating and improve patient understanding and overall satisfaction.

    Primary Objective

    • To identify recurrent verbal and nonverbal communication techniques employed by pediatric oncologists in the delivery of difficult prognostic information to parents through content analysis of audio recorded conversations between pediatric oncologists and parents of children with high-risk cancer at times of disease re-evaluation

    Eligibility Criteria

    Inclusion criteria include:

    Primary oncologist:

    • Attending physician age 18 years or older who provides medical care to patients in the Solid Tumor Clinic at St. Jude Children’s Research Hospital
    • Primary hematology-oncology fellows age 18 or older (audio-recorded disease reevaluation only)

    Parents of children with cancer:

    • Age 18 or older
    • Biological parent, step-parent or primary legal guardian
    • Reads and speaks English

    Patients:

    • Primary oncologist is enrolled in the study.
    • 30 years old or younger
    • Diagnosed with one or more of the  following diseases:
      • High-risk neuroblastoma
      • Any sarcoma
      • Any carcinoma
      • Desmoplastic small round cell tumor
      • Incompletely resected or metastatic retinoblastoma, Wilms tumor or melanoma
      • Disease has relapsed, progressed or not responded to therapy

    Study Sites

    St. Jude Children’s Research Hospital
    Memphis, Tennessee

  2. About this study

    Caring for a child with cancer is a team effort. The patient and parents talk with the cancer doctor, also known as a pediatric oncologist, and other medical team members to make treatment decisions. These discussions can be especially difficult when a child’s cancer has worsened or come back after treatment because the news is not as good as expected.

    This study will evaluate the communication between parents whose children have been treated for certain solid tumors at St. Jude Children’s Research Hospital and the children’s pediatric oncologists.

    Purpose of this clinical trial

    Researchers want to understand better how pediatric oncologists communicate with patient families. They also want to determine what steps doctors can take to improve the way they share information with parents and patients.

  3. U-CHAT Quick View
    Sponsors St. Jude Children’s Research Hospital
    ClinicalTrials.gov identifer NCT02846038
    Trial Start Date July 2016
    Estimated Enrollment 156
    Study Type Observational
    Conditions Neuroblastoma, Wilms Tumor, Sarcoma, Carcinoma, Melanoma, Retinoblastoma, Desmoplastic Small Round Cell Tumor
    Ages 30 years and younger
    Principal Investigator Erica Kaye, MD
    Study Sites St. Jude Children’s Research Hospital 
    For a consultation or to dicuss U-CHAT St. Jude Physician/Patient Referral Office
    1-888-226-4343
    referralinfo@stjude.org

Contact

Erica Kaye, MD

St. Jude Children’s Research Hospital
262 Danny Thomas Place
Memphis, TN 38105  USA
Voice: 1-888-226-4343 or 901-595-4055
24-Hour Emergency Access Pager: 1-800-349-4334

Referring or consulting clinicians only: protocolinfo@stjude.org
For all other inquiries about St. Jude Children's Research Hospital studies: referralinfo@stjude.org

The above information is intended to provide only a basic description about a research protocol that may be currently active at St. Jude. The details made available here may not be the most up-to-date information on protocols used by St. Jude. To receive full details about a protocol and its status and or use at St. Jude, a physician must contact St. Jude directly.